New Peptide ETF From REX Looks Beyond GLP-1 Drugs
Membership required
Membership is now required to use this feature. To learn more:
View Membership BenefitsEmail Commentary Recommendation
Sponsored Content
Upcoming Virtual Events View All
October 15, 2026 at
02:00 PM EDT
- 1.0 CE credit
Midterms, AI and Fed Hikes: A Guide to the Markets with J.P. Morgan
October 16, 2026 at
02:00 PM EDT
- 1.0 CE credit
Accessing the peptide economy
October 20, 2026 at
02:00 PM EDT
- 1.0 CE credit
Higher for Longer: Building More Resilient Fixed Income Portfolios
October 21, 2026 at
02:00 PM EDT
- 1.0 CE credit
Rethinking the Traditional 60/40 with Buffer ETFs
October 22, 2026 at
02:00 PM EDT
- 1.0 CE credit
How Your Clients Could Benefit from a 351 Conversion
October 23, 2026 at
02:00 PM EDT
- 1.0 CE credit
Mid Caps: An Overlooked Source of Growth Potential
October 26, 2026 at
12:30 PM EDT
The Fidelity Factor: Why Fidelity for active ETFs?
October 28, 2026 at
02:00 PM EDT
- 1.0 CE credit
Mining’s new math: Power, compute, and sustainability
October 29, 2026 at
02:00 PM EDT
- 1.0 CE credit
Rethinking Quality: What Free Cash Flow Can Reveal Across the Style Box
November 03, 2026 at
02:00 PM EST
Yield 3.0 – How Autocallable ETFs Are Rewriting the Derivative Income Playbook
November 04, 2026 at
02:00 PM EST
- 1.0 CE credit
Navigate the Evolving Landscape of Options-Based Income ETFs
November 05, 2026 at
12:30 PM EST
Uncovering High-Conviction Mid Cap Opportunities
November 09, 2026 at
12:30 PM EST
Long Live Nuclear: How Extended Reactor Lives Drive Investment Opportunities
November 12, 2026 at
11:00 AM EST
- 1.0 CE credit
2027 Market Outlook Symposium
